Jamie A. Pineda, Ph.D.
Affiliations: | Cognitive Science | University of California, San Diego, La Jolla, CA |
Area:
Neurobiology of social cognition, attention, face perception, addiction, monoamines, brain-computer interfacesWebsite:
http://bci.ucsd.edu/~pineda/CNL_WEBPAGE/index.htmlGoogle:
"Jamie Pineda"Mean distance: 106866
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Datko M, Pineda J, Müller RA. (2017) Positive effects of neurofeedback on autism symptoms correlate with brain activation during imitation and observation. The European Journal of Neuroscience |
| Neukam K, Espinosa N, Collado A, et al. (2016) Hepatic Safety of Rilpivirine/Emtricitabine/Tenofovir Disoproxil Fumarate Fixed-Dose Single-Tablet Regimen in HIV-Infected Patients with Active Hepatitis C Virus Infection: The hEPAtic Study. Plos One. 11: e0155842 |
| Pineda JA, Núñez-Torres R, Téllez F, et al. (2015) Hepatitis C virus reinfection after sustained virological response in HIV-infected patients with chronic hepatitis C. The Journal of Infection. 71: 571-7 |
| Monje-Agudo P, Castro-Iglesias A, Rivero-Juárez A, et al. (2015) Impact of HIV infection on sustained virological response to treatment against hepatitis C virus with pegylated interferon plus ribavirin. European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology. 34: 1929-36 |
| Rockstroh JK, Soriano V, Plonski F, et al. (2015) Hepatic safety in subjects with HIV-1 and hepatitis C and/or B virus: a randomized, double-blind study of maraviroc versus placebo in combination with antiretroviral agents. Hiv Clinical Trials. 16: 72-80 |
| Rivero-Juarez A, Martinez-Dueñas L, Martinez-Peinado A, et al. (2015) Absence of occult Hepatitis E virus infection among HIV immunosuppressed patients. The Journal of Infection. 70: 680-3 |
| MacÃas J, Márquez M, Téllez F, et al. (2013) Risk of liver decompensation among HIV/hepatitis C virus-coinfected individuals with advanced fibrosis: implications for the timing of therapy. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. 57: 1401-8 |
| Rivero-Juárez A, Camacho A, Merchante N, et al. (2013) Incidence of liver damage of uncertain origin in HIV patients not co-infected with HCV/HBV. Plos One. 8: e68953 |
| Neukam K, Barreiro P, MacÃas J, et al. (2013) Chronic hepatitis E in HIV patients: rapid progression to cirrhosis and response to oral ribavirin. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. 57: 465-8 |
| Mira JA, Rivero-Juárez A, López-Cortés LF, et al. (2013) Benefits from sustained virologic response to pegylated interferon plus ribavirin in HIV/hepatitis C virus-coinfected patients with compensated cirrhosis. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. 56: 1646-53 |